Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
OptimizeRx Corporation - Common Stock
(NQ:
OPRX
)
8.830
-0.290 (-3.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OptimizeRx Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
July 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 23, 2024
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide
From
OptimizeRx Corporation
Via
GlobeNewswire
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know
June 21, 2024
Via
Benzinga
Expert Ratings For OptimizeRx
May 15, 2024
Via
Benzinga
Where OptimizeRx Stands With Analysts
April 01, 2024
Via
Benzinga
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023
March 28, 2024
OPRX stock results show that OptimizeRx beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 15, 2024
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program
From
OptimizeRx Corporation
Via
GlobeNewswire
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
June 20, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
May 15, 2024
Via
Benzinga
OptimizeRx Earnings Preview
March 27, 2024
Via
Benzinga
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 15, 2024
Via
Benzinga
Nasdaq Surges 150 Points; Retail Sales Flat For April
May 15, 2024
Via
Benzinga
OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 14, 2024
Via
Benzinga
OptimizeRx Reports First Quarter 2024 Financial Results
May 14, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
May 06, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
April 26, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
April 16, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 11, 2024
Market Embraces Disruptive AI-Powered Capabilities
From
OptimizeRx Corporation
Via
GlobeNewswire
7 Top Undervalued Stocks Primed for a Multibagger Recovery
April 06, 2024
These seven undervalued stocks are trading at discounted prices but have the potential to deliver multibagger returns in the coming years.
Via
InvestorPlace
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
March 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 11, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
March 04, 2024
Empowering healthcare providers to remove barriers to care
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
February 21, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
January 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
January 09, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
December 18, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.